A novel TLR4 binding protein, 40S ribosomal protein S3, has potential utility as an adjuvant in a dendritic cell-based vaccine.
J Immunother Cancer
; 7(1): 60, 2019 02 28.
Article
in En
| MEDLINE
| ID: mdl-30819254
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Ribosomal Proteins
/
Dendritic Cells
/
Adjuvants, Immunologic
/
Cancer Vaccines
/
Toll-Like Receptor 4
Limits:
Animals
/
Female
/
Humans
Language:
En
Journal:
J Immunother Cancer
Year:
2019
Document type:
Article
Affiliation country:
Country of publication: